Preparation, Characterization, and Antimicrobial Activities of Bimetallic Complexes of Sarcosine with Zn(II) and Sn(IV)
Table 5
Antibacterial activity of complexes and ligand against selected bacterial strains.
Compound no.
Bacterial inhibition zone (mm)
S. aureus
B. subtilis
E. coli
P. multocida
HL
12.5c ± 0.86
13.0c ± 1.00
12.5c ± 0.86
12.0c ± 1.41
(1)
20.8bc ± 1.00
18.0c ± 1.00
25.2c ± 0.86
21.0ab ± 1.00
(2)
21.0bc ± 1.00
20.5bc ± 0.86
27.5bc ± 0.86
24.5ab ± 0.86
(3)
20.8bc ± 1.00
18.6c ± 1.00
26.2c ± 0.86
21.3ab ± 1.00
(4)
30.0ab ± 1.41
21.5bc ± 1.65
28.0bc ± 1.41
23.0ab ± 1.00
(5)
32.5ab ± 1.65
54.5a ± 0.86
51.0a ± 1.00
32.5a ± 1.65
(6)
31.5ab ± 0.86
33.0bc ± 1.41
32.0ab ± 1.00
30.0ab ± 1.41
Ampicillin
38.5a ± 0.86
40.0ab ± 1.41
39.5ab ± 0.86
32.0ab ± 1.41
Concentration: 1 mg/mL in DMSO. Standard: ampicillin. 0: no activity, 5–10: activity present, 11–25: moderate activity, 26–40: strong activity. Antibacterial values are mean ± S.D of samples analyzed individually in triplicate at . Different letters in superscript indicate significant differences.